Japan Antifungal Drug Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Antifungal Drug market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Antifungal Drug market. Detailed analysis of key players, along with key growth strategies adopted by Antifungal Drug industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.


    By Player:

    • Sanofi-Aventis

    • Novartis

    • Abbott Laboratories

    • Kramer Laboratories

    • Pfizer

    • Bayer Healthcare

    • Enzon Pharmaceuticals

    • Merck & Co

    • Glaxosmithkline

    • Gilead


    By Type:

    • Echinocandins

    • Azoles

    • Ployenes

    • Allylamines

    • Others


    By End-User:

    • Aspergillosis

    • Dermatophytosis

    • Candidiasis

    • Others


    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Antifungal Drug Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Antifungal Drug Market Size and Growth Rate of Echinocandins from 2014 to 2026

      • 1.3.2 Japan Antifungal Drug Market Size and Growth Rate of Azoles from 2014 to 2026

      • 1.3.3 Japan Antifungal Drug Market Size and Growth Rate of Ployenes from 2014 to 2026

      • 1.3.4 Japan Antifungal Drug Market Size and Growth Rate of Allylamines from 2014 to 2026

      • 1.3.5 Japan Antifungal Drug Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Japan Antifungal Drug Market Size and Growth Rate of Aspergillosis from 2014 to 2026

      • 1.4.2 Japan Antifungal Drug Market Size and Growth Rate of Dermatophytosis from 2014 to 2026

      • 1.4.3 Japan Antifungal Drug Market Size and Growth Rate of Candidiasis from 2014 to 2026

      • 1.4.4 Japan Antifungal Drug Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Antifungal Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Antifungal Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Antifungal Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Antifungal Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Antifungal Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Antifungal Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Antifungal Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Antifungal Drug Consumption Market Size and Growth Rate from 2014 to 2026


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Antifungal Drug Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Antifungal Drug by Major Types

      • 3.4.1 Market Size and Growth Rate of Echinocandins

      • 3.4.2 Market Size and Growth Rate of Azoles

      • 3.4.3 Market Size and Growth Rate of Ployenes

      • 3.4.4 Market Size and Growth Rate of Allylamines

      • 3.4.5 Market Size and Growth Rate of Others


    4 Segmentation of Antifungal Drug Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Antifungal Drug by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Antifungal Drug in Aspergillosis

      • 4.4.2 Market Size and Growth Rate of Antifungal Drug in Dermatophytosis

      • 4.4.3 Market Size and Growth Rate of Antifungal Drug in Candidiasis

      • 4.4.4 Market Size and Growth Rate of Antifungal Drug in Others


    5 Market Analysis by Regions

    • 5.1 Japan Antifungal Drug Production Analysis by Regions

    • 5.2 Japan Antifungal Drug Consumption Analysis by Regions


    6 Hokkaido Antifungal Drug Landscape Analysis

    • 6.1 Hokkaido Antifungal Drug Landscape Analysis by Major Types

    • 6.2 Hokkaido Antifungal Drug Landscape Analysis by Major End-Users


    7 Tohoku Antifungal Drug Landscape Analysis

    • 7.1 Tohoku Antifungal Drug Landscape Analysis by Major Types

    • 7.2 Tohoku Antifungal Drug Landscape Analysis by Major End-Users


    8 Kanto Antifungal Drug Landscape Analysis

    • 8.1 Kanto Antifungal Drug Landscape Analysis by Major Types

    • 8.2 Kanto Antifungal Drug Landscape Analysis by Major End-Users


    9 Chubu Antifungal Drug Landscape Analysis

    • 9.1 Chubu Antifungal Drug Landscape Analysis by Major Types

    • 9.2 Chubu Antifungal Drug Landscape Analysis by Major End-Users


    10 Kinki Antifungal Drug Landscape Analysis

    • 10.1 Kinki Antifungal Drug Landscape Analysis by Major Types

    • 10.2 Kinki Antifungal Drug Landscape Analysis by Major End-Users


    11 Chugoku Antifungal Drug Landscape Analysis

    • 11.1 Chugoku Antifungal Drug Landscape Analysis by Major Types

    • 11.2 Chugoku Antifungal Drug Landscape Analysis by Major End-Users


    12 Shikoku Antifungal Drug Landscape Analysis

    • 12.1 Shikoku Antifungal Drug Landscape Analysis by Major Types

    • 12.2 Shikoku Antifungal Drug Landscape Analysis by Major End-Users


    13 Kyushu Antifungal Drug Landscape Analysis

    • 13.1 Kyushu Antifungal Drug Landscape Analysis by Major Types

    • 13.2 Kyushu Antifungal Drug Landscape Analysis by Major End-Users


    14 Major Players Profiles

    • 14.1 Sanofi-Aventis

      • 14.1.1 Sanofi-Aventis Company Profile and Recent Development

      • 14.1.2 Market Performance

      • 14.1.3 Product and Service Introduction

    • 14.2 Novartis

      • 14.2.1 Novartis Company Profile and Recent Development

      • 14.2.2 Market Performance

      • 14.2.3 Product and Service Introduction

    • 14.3 Abbott Laboratories

      • 14.3.1 Abbott Laboratories Company Profile and Recent Development

      • 14.3.2 Market Performance

      • 14.3.3 Product and Service Introduction

    • 14.4 Kramer Laboratories

      • 14.4.1 Kramer Laboratories Company Profile and Recent Development

      • 14.4.2 Market Performance

      • 14.4.3 Product and Service Introduction

    • 14.5 Pfizer

      • 14.5.1 Pfizer Company Profile and Recent Development

      • 14.5.2 Market Performance

      • 14.5.3 Product and Service Introduction

    • 14.6 Bayer Healthcare

      • 14.6.1 Bayer Healthcare Company Profile and Recent Development

      • 14.6.2 Market Performance

      • 14.6.3 Product and Service Introduction

    • 14.7 Enzon Pharmaceuticals

      • 14.7.1 Enzon Pharmaceuticals Company Profile and Recent Development

      • 14.7.2 Market Performance

      • 14.7.3 Product and Service Introduction

    • 14.8 Merck & Co

      • 14.8.1 Merck & Co Company Profile and Recent Development

      • 14.8.2 Market Performance

      • 14.8.3 Product and Service Introduction

    • 14.9 Glaxosmithkline

      • 14.9.1 Glaxosmithkline Company Profile and Recent Development

      • 14.9.2 Market Performance

      • 14.9.3 Product and Service Introduction

    • 14.10 Gilead

      • 14.10.1 Gilead Company Profile and Recent Development

      • 14.10.2 Market Performance

      • 14.10.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 92 Figures and 166 Tables)

     

    • Figure Japan Antifungal Drug Market Size and Growth Rate of Echinocandins from 2014 to 2026

    • Figure Japan Antifungal Drug Market Size and Growth Rate of Azoles from 2014 to 2026

    • Figure Japan Antifungal Drug Market Size and Growth Rate of Ployenes from 2014 to 2026

    • Figure Japan Antifungal Drug Market Size and Growth Rate of Allylamines from 2014 to 2026

    • Figure Japan Antifungal Drug Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Japan Antifungal Drug Market Size and Growth Rate of Aspergillosis from 2014 to 2026

    • Figure Japan Antifungal Drug Market Size and Growth Rate of Dermatophytosis from 2014 to 2026

    • Figure Japan Antifungal Drug Market Size and Growth Rate of Candidiasis from 2014 to 2026

    • Figure Japan Antifungal Drug Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Antifungal Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Antifungal Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Antifungal Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Antifungal Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Antifungal Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Antifungal Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Antifungal Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Antifungal Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Antifungal Drug Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Antifungal Drug

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Antifungal Drug by Different Types from 2014 to 2026

    • Table Consumption Share of Antifungal Drug by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Echinocandins

    • Figure Market Size and Growth Rate of Azoles

    • Figure Market Size and Growth Rate of Ployenes

    • Figure Market Size and Growth Rate of Allylamines

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Antifungal Drug by Different End-Users from 2014 to 2026

    • Table Consumption Share of Antifungal Drug by Different End-Users from 2014 to 2026

    • Figure Japan Antifungal Drug Market Size and Growth Rate of Aspergillosis from 2014 to 2026

    • Figure Japan Antifungal Drug Market Size and Growth Rate of Dermatophytosis from 2014 to 2026

    • Figure Japan Antifungal Drug Market Size and Growth Rate of Candidiasis from 2014 to 2026

    • Figure Japan Antifungal Drug Market Size and Growth Rate of Others from 2014 to 2026

    • Table Japan Antifungal Drug Production by Regions

    • Table Japan Antifungal Drug Production Share by Regions

    • Figure Japan Antifungal Drug Production Share by Regions in 2014

    • Figure Japan Antifungal Drug Production Share by Regions in 2018

    • Figure Japan Antifungal Drug Production Share by Regions in 2026

    • Table Japan Antifungal Drug Consumption by Regions

    • Table Japan Antifungal Drug Consumption Share by Regions

    • Figure Japan Antifungal Drug Consumption Share by Regions in 2014

    • Figure Japan Antifungal Drug Consumption Share by Regions in 2018

    • Figure Japan Antifungal Drug Consumption Share by Regions in 2026

    • Table Hokkaido Antifungal Drug Consumption by Types from 2014 to 2026

    • Table Hokkaido Antifungal Drug Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Antifungal Drug Consumption Share by Types in 2014

    • Figure Hokkaido Antifungal Drug Consumption Share by Types in 2018

    • Figure Hokkaido Antifungal Drug Consumption Share by Types in 2026

    • Table Hokkaido Antifungal Drug Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Antifungal Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Antifungal Drug Consumption Share by End-Users in 2014

    • Figure Hokkaido Antifungal Drug Consumption Share by End-Users in 2018

    • Figure Hokkaido Antifungal Drug Consumption Share by End-Users in 2026

    • Table Tohoku Antifungal Drug Consumption by Types from 2014 to 2026

    • Table Tohoku Antifungal Drug Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Antifungal Drug Consumption Share by Types in 2014

    • Figure Tohoku Antifungal Drug Consumption Share by Types in 2018

    • Figure Tohoku Antifungal Drug Consumption Share by Types in 2026

    • Table Tohoku Antifungal Drug Consumption by End-Users from 2014 to 2026

    • Table Tohoku Antifungal Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Antifungal Drug Consumption Share by End-Users in 2014

    • Figure Tohoku Antifungal Drug Consumption Share by End-Users in 2018

    • Figure Tohoku Antifungal Drug Consumption Share by End-Users in 2026

    • Table Kanto Antifungal Drug Consumption by Types from 2014 to 2026

    • Table Kanto Antifungal Drug Consumption Share by Types from 2014 to 2026

    • Figure Kanto Antifungal Drug Consumption Share by Types in 2014

    • Figure Kanto Antifungal Drug Consumption Share by Types in 2018

    • Figure Kanto Antifungal Drug Consumption Share by Types in 2026

    • Table Kanto Antifungal Drug Consumption by End-Users from 2014 to 2026

    • Table Kanto Antifungal Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Antifungal Drug Consumption Share by End-Users in 2014

    • Figure Kanto Antifungal Drug Consumption Share by End-Users in 2018

    • Figure Kanto Antifungal Drug Consumption Share by End-Users in 2026

    • Table Chubu Antifungal Drug Consumption by Types from 2014 to 2026

    • Table Chubu Antifungal Drug Consumption Share by Types from 2014 to 2026

    • Figure Chubu Antifungal Drug Consumption Share by Types in 2014

    • Figure Chubu Antifungal Drug Consumption Share by Types in 2018

    • Figure Chubu Antifungal Drug Consumption Share by Types in 2026

    • Table Chubu Antifungal Drug Consumption by End-Users from 2014 to 2026

    • Table Chubu Antifungal Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Antifungal Drug Consumption Share by End-Users in 2014

    • Figure Chubu Antifungal Drug Consumption Share by End-Users in 2018

    • Figure Chubu Antifungal Drug Consumption Share by End-Users in 2026

    • Table Kinki Antifungal Drug Consumption by Types from 2014 to 2026

    • Table Kinki Antifungal Drug Consumption Share by Types from 2014 to 2026

    • Figure Kinki Antifungal Drug Consumption Share by Types in 2014

    • Figure Kinki Antifungal Drug Consumption Share by Types in 2018

    • Figure Kinki Antifungal Drug Consumption Share by Types in 2026

    • Table Kinki Antifungal Drug Consumption by End-Users from 2014 to 2026

    • Table Kinki Antifungal Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Antifungal Drug Consumption Share by End-Users in 2014

    • Figure Kinki Antifungal Drug Consumption Share by End-Users in 2018

    • Figure Kinki Antifungal Drug Consumption Share by End-Users in 2026

    • Table Chugoku Antifungal Drug Consumption by Types from 2014 to 2026

    • Table Chugoku Antifungal Drug Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Antifungal Drug Consumption Share by Types in 2014

    • Figure Chugoku Antifungal Drug Consumption Share by Types in 2018

    • Figure Chugoku Antifungal Drug Consumption Share by Types in 2026

    • Table Chugoku Antifungal Drug Consumption by End-Users from 2014 to 2026

    • Table Chugoku Antifungal Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Antifungal Drug Consumption Share by End-Users in 2014

    • Figure Chugoku Antifungal Drug Consumption Share by End-Users in 2018

    • Figure Chugoku Antifungal Drug Consumption Share by End-Users in 2026

    • Table Shikoku Antifungal Drug Consumption by Types from 2014 to 2026

    • Table Shikoku Antifungal Drug Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Antifungal Drug Consumption Share by Types in 2014

    • Figure Shikoku Antifungal Drug Consumption Share by Types in 2018

    • Figure Shikoku Antifungal Drug Consumption Share by Types in 2026

    • Table Shikoku Antifungal Drug Consumption by End-Users from 2014 to 2026

    • Table Shikoku Antifungal Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Antifungal Drug Consumption Share by End-Users in 2014

    • Figure Shikoku Antifungal Drug Consumption Share by End-Users in 2018

    • Figure Shikoku Antifungal Drug Consumption Share by End-Users in 2026

    • Table Kyushu Antifungal Drug Consumption by Types from 2014 to 2026

    • Table Kyushu Antifungal Drug Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Antifungal Drug Consumption Share by Types in 2014

    • Figure Kyushu Antifungal Drug Consumption Share by Types in 2018

    • Figure Kyushu Antifungal Drug Consumption Share by Types in 2026

    • Table Kyushu Antifungal Drug Consumption by End-Users from 2014 to 2026

    • Table Kyushu Antifungal Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Antifungal Drug Consumption Share by End-Users in 2014

    • Figure Kyushu Antifungal Drug Consumption Share by End-Users in 2018

    • Figure Kyushu Antifungal Drug Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of Sanofi-Aventis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi-Aventis

    • Figure Sales and Growth Rate Analysis of Sanofi-Aventis

    • Figure Revenue and Market Share Analysis of Sanofi-Aventis

    • Table Product and Service Introduction of Sanofi-Aventis

    • Table Company Profile and Development Status of Novartis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis

    • Table Company Profile and Development Status of Abbott Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories

    • Figure Sales and Growth Rate Analysis of Abbott Laboratories

    • Figure Revenue and Market Share Analysis of Abbott Laboratories

    • Table Product and Service Introduction of Abbott Laboratories

    • Table Company Profile and Development Status of Kramer Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kramer Laboratories

    • Figure Sales and Growth Rate Analysis of Kramer Laboratories

    • Figure Revenue and Market Share Analysis of Kramer Laboratories

    • Table Product and Service Introduction of Kramer Laboratories

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Bayer Healthcare

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer Healthcare

    • Figure Sales and Growth Rate Analysis of Bayer Healthcare

    • Figure Revenue and Market Share Analysis of Bayer Healthcare

    • Table Product and Service Introduction of Bayer Healthcare

    • Table Company Profile and Development Status of Enzon Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Enzon Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Enzon Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Enzon Pharmaceuticals

    • Table Product and Service Introduction of Enzon Pharmaceuticals

    • Table Company Profile and Development Status of Merck & Co

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co

    • Figure Sales and Growth Rate Analysis of Merck & Co

    • Figure Revenue and Market Share Analysis of Merck & Co

    • Table Product and Service Introduction of Merck & Co

    • Table Company Profile and Development Status of Glaxosmithkline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Glaxosmithkline

    • Figure Sales and Growth Rate Analysis of Glaxosmithkline

    • Figure Revenue and Market Share Analysis of Glaxosmithkline

    • Table Product and Service Introduction of Glaxosmithkline

    • Table Company Profile and Development Status of Gilead

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gilead

    • Figure Sales and Growth Rate Analysis of Gilead

    • Figure Revenue and Market Share Analysis of Gilead

    • Table Product and Service Introduction of Gilead

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.